Gamma-Tubulin Is Required for Bipolar Spindle Assembly and for Proper Kinetochore Microtubule Attachments during Prometaphase I in Drosophila Oocytes

Por Hughes, Stacie E., Beeler, J. Scott, Seat, Angela, Slaughter, Brian D., Unruh, Jay R., Bauerly, Elisabeth, Matthies, Heinrich J. G., Hawley, R. Scott
Publicado em 2011

Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies

Por Shaver, Timothy M., Lehmann, Brian D., Beeler, J. Scott, Li, Chung-I, Li, Zhu, Jin, Hailing, Stricker, Thomas P., Shyr, Yu, Pietenpol, Jennifer A.
Publicado no Cancer Res (2016)

Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer

Por Jovanović, Bojana, Beeler, J Scott, Pickup, Michael W, Chytil, Anna, Gorska, Agnieszka E, Ashby, William J, Lehmann, Brian D, Zijlstra, Andries, Pietenpol, Jennifer A, Moses, Harold L
Publicado em 2014

p73 Is Required for Ovarian Follicle Development and Regulates a Gene Network Involved in Cell-to-Cell Adhesion

Por Santos Guasch, Gabriela L., Beeler, J Scott, Marshall, Clayton B., Shaver, Timothy M., Sheng, Quanhu, Johnson, Kimberly N., Boyd, Kelli L., Venters, Bryan J., Cook, Rebecca S., Pietenpol, Jennifer A.
Publicado no iScience (2018)

p73 regulates epidermal wound healing and induced keratinocyte programming

Por Beeler, J. Scott, Marshall, Clayton B., Gonzalez-Ericsson, Paula I., Shaver, Timothy M., Santos Guasch, Gabriela L., Lea, Spencer T., Johnson, Kimberly N., Jin, Hailing, Venters, Bryan J., Sanders, Melinda E., Pietenpol, Jennifer A.
Publicado no PLoS One (2019)

p73 is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network

Por Marshall, Clayton B, Mays, Deborah J, Beeler, J Scott, Rosenbluth, Jennifer M, Boyd, Kelli L, Guasch, Gabriela L Santos, Shaver, Timothy M, Tang, Lucy J, Liu, Qi, Shyr, Yu, Venters, Bryan J, Magnuson, Mark A, Pietenpol, Jennifer A
Publicado no Cell Rep (2016)

Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors

Por Schafer, Johanna M., Lehmann, Brian D., Gonzalez-Ericsson, Paula I., Marshall, Clayton B., Beeler, J. Scott, Redman, Lindsay N., Jin, Hailing, Sanchez, Violeta, Stubbs, Matthew C., Scherle, Peggy, Johnson, Kimberly N., Sheng, Quanhu, Roland, Joseph T., Bauer, Joshua A., Shyr, Yu, Chakravarthy, Bapsi, Mobley, Bret C., Hiebert, Scott W., Balko, Justin M., Sanders, Melinda E., Liu, Phillip C.C., Pietenpol, Jennifer A.
Publicado no Sci Transl Med (2020)

A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): Responses and long-t...

Por Jovanović, Bojana, Mayer, Ingrid A., Mayer, Erica L., Abramson, Vandana G., Bardia, Aditya, Sanders, Melinda E., Kuba, M. Gabriela, Estrada, Monica V., Beeler, J. Scott, Shaver, Timothy M., Johnson, Kimberly C., Sanchez, Violeta, Rosenbluth, Jennifer M., Dillon, Patrick M., Forero-Torres, Andres, Chang, Jenny C., Meszoely, Ingrid M., Grau, Ana M., Lehmann, Brian D., Shyr, Yu, Sheng, Quanhu, Chen, Sheau-Chiann, Arteaga, Carlos L., Pietenpol, Jennifer A.
Publicado no Clin Cancer Res (2017)